Tyler S Garman

4PUBLICATIONS
3CO-AUTHORS
Medical biotechnology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)International accountingReproductive medicine not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 30, 2026
The FDA Should Allow More BCG Strains into the US Market: How Recent Landmark Trials Expose a Regulatory Paradox.

|Jun 22, 2026
Phase 2 Trial of Intravesical Gemcitabine and Docetaxel as First-Line Treatment of Bacillus Calmette-Guérin (BCG)‒Naïve Non-Muscle-Invasive Urothelial Carcinoma: Updated, 3-Year Outcomes.

|Feb 18, 2026
Trends in Industry-Sponsored Research Payments and General Payments to Neurologists: Open Payments Program 2015-2023.

Tyler S Garman, Zeyad Hammadeh, Misop Han

|Jan 11, 2023
AUA-Recommended Antibiotic Prophylaxis for Primary Penile Implantation Results in a Higher, Not Lower, Risk for Postoperative Infection: A Multicenter Analysis. Letter.

Tyler S Garman, Bruce J Trock

Pageof 1

Frequent Collaborators

1 joint publications

Zeyad Hammadeh

1 joint publications

Misop Han

1 joint publications

Joon Y Kang